# Madrigal Pharmaceuticals, Inc.: Form 8-K, filed May 9, 2023

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: 8-K
- Filed: 2023-05-09
- Accepted by EDGAR: May 9, 2023, 08:00 ET
- Period: 2023-05-09
- Accession: 0001193125-23-138931
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000119312523138931/d398921d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000119312523138931/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000119312523138931/d398921d8k.htm

Filed May 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-138931. Last ingested by Listed: Nov 6, 2026, 18:49 ET. No prices; not investment advice.
